Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
FTV · 10-Q filed July 29, 2026

FTV earnings analysis

What we found in FTV's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

The supplied 10-Q excerpt does not include the income statement, segment data, balance sheet, or cash-flow statements, so revenue, margins, EPS, free cash flow, and period-over-period trends cannot be verified from the filing text provided. The principal disclosed capital-allocation item was the repurchase of 3,360,283 shares at $59.54 per share during Q2. Management reported no material risk-factor changes for the quarter ended July 3, 2026 and stated that disclosure controls were effective.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Meaningful quarterly share repurchases
Fortive repurchased 3,360,283 shares during the quarter ended July 3, 2026, at an average price of $59.54 per share. The Board also authorized 14.4 million new shares on May 4, 2026.
Repurchase capacity remains available
After quarterly repurchases, the General Share Repurchase Program had 17.7 million shares available and the Special Share Repurchase Program had $66.7 million available as of July 3, 2026.
Controls assessed as effective
Management concluded that disclosure controls and procedures were effective as of July 3, 2026, and reported no material changes in internal control over financial reporting during the quarter.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

No material risk-factor updates
The filing states that there were no material changes in risk factors during the quarter ended July 3, 2026. Accordingly, this 10-Q does not identify a newly escalated risk relative to the 2025 Form 10-K.
Buyback execution remains discretionary
The $66.7 million Special Share Repurchase Program balance and 17.7 million-share General Program authorization may be suspended or discontinued at any time by the Board, limiting certainty around future capital returns.
Guidance

What they said about what is next.

The supplied 10-Q excerpt contains no quantitative revenue or EPS outlook. Quantitative guidance appears to have been addressed in the contemporaneous earnings release rather than this filing excerpt.

How we read the filing overall

The filing reads about the same as the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · April 30, 2026
Fortive Corporation reported its Q1 2026 results, showing a revenue of $1.07 billion and an adjusted EPS of $0.70, both reflecting positive year-over-year growth but falling short of analyst expectations. Management…
10-K · February 25, 2026
Fortive’s 10-K emphasizes the “Fortive Accelerated” strategy powered by the Fortive Business System (FBS) to deliver faster profitable growth, disciplined capital allocation and investor trust. The company operates two…
10-K · February 25, 2025
Fortive’s 10-K emphasizes a portfolio strategy across three segments (Intelligent Operating Solutions, Precision Technologies, Advanced Healthcare Solutions), continued deployment of the Fortive Business System (FBS)…
10-Q · July 24, 2024
Fortive reported quarterly sales of $1,552.4 million (up $26.0 million vs. $1,526.4 million a year ago) with gross profit of $928.3 million and operating profit of $301.8 million. Diluted EPS declined to $0.55 from…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing FTV makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever